Ownership history in Affinity Asset Advisors, LLC · 4 quarters on record
This page tracks every 13F SEC filing in which Affinity Asset Advisors, LLC reported a position in OVID THERAPEUTICS INC (OVID). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 7,150,000 | +4,500,000 | +169.8% | 0.66% | $11.7M | $1.63 |
| 2025 Q3 | ADDED | 2,650,000 | +1,982,484 | +297.0% | 0.30% | $3.4M | $1.30 |
| 2025 Q2 | UNCHANGED | 667,516 | — | 0% | 0.03% | $220K | $0.33 |
| 2025 Q1 | INITIATED | 667,516 | — | — | 0.02% | $208K | $0.31 |
As of 2025 Q4 — sorted by position size